Aqueous Benzylic C–H Trifluoromethylation for Late-Stage Functionalization
作者:Shuo Guo、Deyaa I. AbuSalim、Silas P. Cook
DOI:10.1021/jacs.8b08547
日期:2018.10.3
The installation of trifluoromethylgroups has become an essential step across a number of industries such as agrochemicals, drug discovery, and materials. Consequently, the rapid introduction of this critical functional group in a predictable fashion would benefit current practitioners in those fields. This communication describes a mild trifluoromethylation of benzylic C-H bonds with high selectivity
The present invention covers 2-methyl-aza-quinazoline compounds of general formula (I) as described and defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients.
Copper‐Mediated Trifluoromethylation of Benzylic Csp
<sup>3</sup>
−H Bonds
作者:Matthew Paeth、William Carson、Jheng‐Hua Luo、David Tierney、Zhi Cao、Mu‐Jeng Cheng、Wei Liu
DOI:10.1002/chem.201802766
日期:2018.8.9
Trifluoromethyl‐containing compounds play a significant role in medicinal chemistry, materials and fine chemistry. Although direct C−H trifluoromethylation has been achieved on Csp2−H bonds, direct conversion of Csp3−H bonds to Csp3−CF3 remains challenging. We report herein an efficient protocol for the selective trifluoromethylation of benzylic C−H bonds. This process is mediated by a combination
NOVEL BENZYLAMINO SUBSTITUTED PYRIDOPYRIMIDINONES AND DERIVATIVES AS SOS1 INHIBITORS
申请人:Boehringer Ingelheim International GmbH
公开号:US20190194192A1
公开(公告)日:2019-06-27
The present invention encompasses compounds of formula (I)
wherein the groups R
1
to R
4
, A and p have the meanings given in the claims and specification, their use as inhibitors of SOS1, pharmaceutical compositions which contain compounds of this kind and their use as medicaments/medical uses, especially as agents for treatment and/or prevention of oncological diseases.